1. Alcohol consumption and breast cancer prognosis after breast cancer diagnosis: a systematic review and meta‑analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2022 edition

   • Tsunehisa Nomura
   • Masaaki Kawai
   • Shigehira Saji

   Special Article Open access 08 April 2023 Pages: 519 - 530

   

2. Efficacy and safety of surgical energy devices for axillary node dissection: a systematic review and network meta-analysis

   • Jun Watanabe
   • Yuki Kataoka
   • Naohiro Sata

   Review Article 14 April 2023 Pages: 531 - 540

   

3. Validity of computed mean compressed fibroglandular tissue thickness and breast composition for stratification of masking risk in Japanese women

   • Mikinao Oiwa
   • Namiko Suda
   • Tokiko Endo

   Original Article 15 March 2023 Pages: 541 - 551

   

4. Centrally located breast carcinomas treated with central quadrantectomy and immediate nipple–areola reconstruction: a cohort study

   • Hernanz Fernando
   • González Noelia
   • Muñoz Pedro

   ORIGINAL ARTICLE 03 March 2023 Pages: 552 - 558

   

5. Cell-free biomimetic polyurethane-based scaffold for breast reconstruction following non-malignant lesion resection. A first-in-human study

   • Maria Donatella Mariniello
   • Matteo Ghilli
   • Manuela Roncella

   Original Article 28 March 2023 Pages: 559 - 569

   

6. Development and implementation of a decision aid for post-mastectomy breast reconstruction for Japanese women with breast cancer: a field-testing study

   • Yoshihiro Sowa
   • Naoki Inafuku
   • Naoki Morimoto

   Original Article 18 March 2023 Pages: 570 - 576

   

7. Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study

   • Mari Kikuchi
   • Naoya Gomi
   • Takashi Terauchi

   Original Article 10 March 2023 Pages: 577 - 583

   

8. Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients

   • Masayuki Nagahashi
   • YiWei Ling
   • Toshifumi Wakai

   Original Article 17 March 2023 Pages: 584 - 595

   

9. Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial

   • Hideko Yamauchi
   • Masakazu Toi
   • Andrew Tutt

   Original Article Open access 01 April 2023 Pages: 596 - 605

   

10. Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial

    • Hideko Yamauchi
    • Masakazu Toi
    • Andrew Tutt

    Correction Open access 12 May 2023 Pages: 606 - 606

11. Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry

    • Shozo Ohsumi
    • Kenichi Watanabe
    • Hirofumi Mukai

    Original Article Open access 17 April 2023 Pages: 607 - 616

    

12. Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study

    • Murat Akyol
    • Alper Tuğral
    • Yeşim Bakar

    Original Article 23 March 2023 Pages: 617 - 626

    

13. Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare

    • Rashmi Pathak
    • Macall Leslie
    • Takemi Tanaka

    Original Article Open access 03 May 2023 Pages: 627 - 636

    

14. High-accuracy prediction of axillary lymph node metastasis in invasive lobular carcinoma using focal cortical thickening on magnetic resonance imaging

    • Shun Kawaguchi
    • Keiichi Kinowaki
    • Hidetaka Kawabata

    Original Article 05 April 2023 Pages: 637 - 646

    

15. Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2–N3 status patients: a SEER database analysis

    • Yile Jiao
    • Xinyi Guo
    • Qing Lv

    Original Article 27 April 2023 Pages: 647 - 656

    

16. Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan

    • K. Nozawa
    • M. Terada
    • Junji Tsurutani

    Original Article Open access 22 May 2023 Pages: 657 - 665

    

17. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation

    • Leilei Li
    • Wenhui Yang
    • Guanghui Wang

    Original Article Open access 13 May 2023 Pages: 666 - 684

    

18. The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees

    • Kazumi Jinbo
    • Takaaki Fujita
    • Yuichi Yamamoto

    Rapid Communication 14 March 2023 Pages: 685 - 688

    

19. Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region

    • Nobumoto Tomioka
    • Kanako C. Hatanaka
    • Masato Takahashi

    Correction Open access 27 April 2023 Pages: 689 - 690